Denali Therapeutics (DNLI) Stock: Buy, Sell, or Hold?
DNLI - Denali Therapeutics Inc. Common Stock
$18.35
0.47 (2.66%)
▲
5d:
-1.74%
30d:
-8.55%
90d:
-21.23%
HOLD
MODERATE Confidence
Analysis Updated: Oct 15, 2026 12:00 AM ET
Earnings: Nov 05, 2026
20d
Get Alerted When DNLI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DNLI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: DNLI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: DNLI is currently trading at $18.34, which is considered oversold relative to its 30-day fair value range of $19.20 to $21.22.
Technical Outlook: Technically, DNLI is in a uptrend. Immediate support is located at $17.53, while resistance sits at $20.85.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $35.75 (+100.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DNLI is in a uptrend. Immediate support is located at $17.53, while resistance sits at $20.85.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $35.75 (+100.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$19.20 -
$21.22
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (52/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 100.1% below Wall St target ($35.75)
- NEUTRAL: Bottoming setup forming (52/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$19.20 -
$21.22
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$17.53
Resistance Level
$20.85
Current Trend
Uptrend
Technical data as of
Oct 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.39
Wall Street Target
$35.75
(+100.1%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: October 15, 2026 12:56 PM ET
Data refreshes hourly during market hours. Next update: 1:56 PM
Data refreshes hourly during market hours. Next update: 1:56 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DNLI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
27 analysts |
$92 | 66 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$285 | 58 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$109 | 65 BUY |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$129 | 72 BUY |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
17 analysts |
$37 | 68 BUY |
